TAK-220, a novel small-molecule CCR5 antagonist, has favorable anti-human immunodeficiency virus interactions with other antiretrovirals in vitro.
about
Potent antiviral synergy between monoclonal antibody and small-molecule CCR5 inhibitors of human immunodeficiency virus type 1Closing the door to human immunodeficiency virus.Highly potent inhibition of human immunodeficiency virus type 1 replication by TAK-220, an orally bioavailable small-molecule CCR5 antagonist.Hendra and nipah infection: pathology, models and potential therapies.Allosteric modulation of seven transmembrane spanning receptors: theory, practice, and opportunities for central nervous system drug discoveryPotent synergistic anti-human immunodeficiency virus (HIV) effects using combinations of the CCR5 inhibitor aplaviroc with other anti-HIV drugsCCR5 inhibitors in HIV-1 therapy.Targeting CCR5 for anti-HIV research.Env-glycoprotein heterogeneity as a source of apparent synergy and enhanced cooperativity in inhibition of HIV-1 infection by neutralizing antibodies and entry inhibitorsPrevention of murine experimental autoimmune encephalomyelitis by in vivo expression of a novel recombinant immunotoxin DT390-RANTES.A guided tour through the antiviral drug field
P2860
Q24673555-F0DDCD1E-6BBE-49A3-BC66-49002250E8ECQ30428089-6A04FA8D-1D3A-4503-811B-DB5DCD5C9F02Q33938250-09E10DA2-4286-4372-9F81-C19F06BD2720Q35658146-77AECB44-9CF9-4FD6-AB71-050100720663Q35952381-300862BF-3774-47D2-88D2-36F287BED779Q36703042-07068F69-5E69-4B76-B7FC-8210B9ED59E1Q38089881-7D960C3E-5DF8-4492-9CE7-BCAA1168423AQ38229805-7BDCDAA8-9C46-44D9-B328-DC7C06D9CC45Q39454698-D8B2F110-47D4-4CAF-B624-EA0250A094D6Q42801736-0F7E2958-76CF-43F6-9FE9-EB4656A3F2A3Q56786373-D45B76A6-9BF7-45F7-A113-EC37B5D5D51A
P2860
TAK-220, a novel small-molecule CCR5 antagonist, has favorable anti-human immunodeficiency virus interactions with other antiretrovirals in vitro.
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
TAK-220, a novel small-molecul ...... other antiretrovirals in vitro
@nl
TAK-220, a novel small-molecul ...... ther antiretrovirals in vitro.
@ast
TAK-220, a novel small-molecul ...... ther antiretrovirals in vitro.
@en
TAK-220, a novel small-molecul ...... ther antiretrovirals in vitro.
@en-gb
type
label
TAK-220, a novel small-molecul ...... other antiretrovirals in vitro
@nl
TAK-220, a novel small-molecul ...... ther antiretrovirals in vitro.
@ast
TAK-220, a novel small-molecul ...... ther antiretrovirals in vitro.
@en
TAK-220, a novel small-molecul ...... ther antiretrovirals in vitro.
@en-gb
prefLabel
TAK-220, a novel small-molecul ...... other antiretrovirals in vitro
@nl
TAK-220, a novel small-molecul ...... ther antiretrovirals in vitro.
@ast
TAK-220, a novel small-molecul ...... ther antiretrovirals in vitro.
@en
TAK-220, a novel small-molecul ...... ther antiretrovirals in vitro.
@en-gb
P2093
P2860
P1476
TAK-220, a novel small-molecul ...... ther antiretrovirals in vitro.
@en
P2093
Cécile L Tremblay
Françoise Giguel
Katsunori Takashima
Martin S Hirsch
Ting-Chao Chou
Yongbiao Guan
P2860
P304
P356
10.1128/AAC.49.8.3483-3485.2005
P407
P577
2005-08-01T00:00:00Z